Mechanisms of myofibroblast survival in fibrosis
纤维化过程中肌成纤维细胞的存活机制
基本信息
- 批准号:6616355
- 负责人:
- 金额:$ 28.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(Applicant's Abstract) Idiopathic pulmonary fibrosis/usual interstitial
pneumonitis (IPF/UIP) is a fatal parenchymal lung disease characterized by
interstitial and alveolar fibroproliferation and the appearance of
myofibroblasts. Little is known about the mechanisms of myofibroblast
accumulation in IPF/UIP or why they fail to be eliminated as occurs during
normal wound repair. Previous studies from this and other laboratories have
shown that survival factors, especially IGF-I, are abundantly expressed by
macrophages and alveolar epithelial cells in IPF/UIP. In this proposal, we
will test the hypothesis that the presence of survival factors, including IGF-I,
in the parenchyma and airspaces of patients with IPF/UIP protect
myofibroblasts from apoptosis. Under these conditions, myofibroblasts are
proposed to accumulate in numbers and can thus contribute to parenchymal
fibrosis for extended periods of time. The major goals of this proposal are
three-fold: (i) to investigate the conditions and mechanisms that mediate
myofibroblast apoptosis under conditions of growth factor and stretch
withdrawal; (ii) to determine how IGF-I serves to protect myofibroblasts from
undergoing apoptosis; and (iii) to investigate the mechanism of dysregulation
of myofibroblast apoptosis in IPF/UIP. These goals will be addressed by four
specific aims. Specific aim one will address the role of growth factors,
physical forces and IGF-I in myofibroblast differentiation, reversion to a
fibroblast phenotype and apoptosis. These studies will form a basis for
determining the mechanisms that promote myofibroblast apoptosis with a focus
on the mechanisms of caspase activation (specific aim two). The objective of
specific aim three is to uncover the mechanisms through which IGF-I prevents
the initiation of the death program. The focus of these studies will include
the mechanism of inactivation of the effector capsases (3, 6 and 7) and the
potential role of anti-apoptotic proteins. Lastly, in specific aim four, we
propose to apply what has been learned from this studies conducted in this
proposal to address the mechanisms that promote protection from apoptosis in
the lungs of patients with IPF/UIP. The findings from this work are expected
to provide new insights into the mechanism of myofibroblast apoptosis and how
this process becomes dysregulated in IPF/UIP.
(申请人摘要)特发性肺纤维化/常见间质性
肺炎(IPF/UIP)是一种致死性实质性肺病,其特征为
间质和肺泡纤维增生,
肌成纤维细胞肌成纤维细胞的作用机制尚不清楚,
IPF/UIP中的蓄积,或者为什么它们在
正常的伤口修复该实验室和其他实验室的先前研究
显示存活因子,特别是IGF-I,在细胞中大量表达,
巨噬细胞和肺泡上皮细胞。在本提案中,我们
将检验生存因子,包括IGF-I,
在IPF/UIP患者的实质和气隙中保护
肌成纤维细胞凋亡。在这些条件下,肌成纤维细胞
建议在数量上积累,因此可以有助于实质
纤维化持续时间长。这项建议的主要目标是
三方面:(一)调查调解的条件和机制
生长因子和牵张条件下肌成纤维细胞凋亡
退出;(ii)确定IGF-I如何保护肌成纤维细胞免受
进行细胞凋亡;和(iii)研究失调的机制
IPF/UIP中肌成纤维细胞凋亡。这些目标将通过四个方面来实现。
具体目标。具体目标之一是解决生长因子的作用,
物理力和IGF-I在肌成纤维细胞分化中的作用,
成纤维细胞表型和凋亡。这些研究将为
确定促进肌成纤维细胞凋亡的机制,
半胱天冬酶激活机制(具体目标二)。的目标
第三个具体目标是揭示IGF-I预防糖尿病的机制,
死亡计划的启动这些研究的重点将包括
效应物衣壳酶(3、6和7)的失活机制以及
抗凋亡蛋白的潜在作用。最后,在具体目标四中,我们
我建议把从这项研究中学到的东西应用到这个项目中。
建议解决机制,促进保护细胞凋亡,
IPF/UIP患者的肺部。这项工作的结果预计
为肌成纤维细胞凋亡的机制以及
该过程在IPF/UIP中变得失调。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David W. Riches其他文献
David W. Riches的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David W. Riches', 18)}}的其他基金
Targeting early events in MUC5B-driven lung injury and fibrosis
针对 MUC5B 驱动的肺损伤和纤维化的早期事件
- 批准号:
10627600 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema
肺泡间隔成纤维细胞丢失与肺气肿的发病机制
- 批准号:
10609797 - 财政年份:2017
- 资助金额:
$ 28.87万 - 项目类别:
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema
肺泡间隔成纤维细胞丢失与肺气肿的发病机制
- 批准号:
10367957 - 财政年份:2017
- 资助金额:
$ 28.87万 - 项目类别:
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis
PTPN13 在特发性肺纤维化中的治疗靶向
- 批准号:
9142965 - 财政年份:2017
- 资助金额:
$ 28.87万 - 项目类别:
Aspen Lung Conference: Rebuilding the Injured Lung
阿斯彭肺会议:重建受伤的肺
- 批准号:
8711900 - 财政年份:2014
- 资助金额:
$ 28.87万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
8503966 - 财政年份:2013
- 资助金额:
$ 28.87万 - 项目类别:
Initial functional characterization of TRUSS-deficient mice
TRUSS 缺陷小鼠的初步功能表征
- 批准号:
8511974 - 财政年份:2013
- 资助金额:
$ 28.87万 - 项目类别:
Initial functional characterization of TRUSS-deficient mice
TRUSS 缺陷小鼠的初步功能表征
- 批准号:
8649023 - 财政年份:2013
- 资助金额:
$ 28.87万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
8665478 - 财政年份:2013
- 资助金额:
$ 28.87万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
9066180 - 财政年份:2013
- 资助金额:
$ 28.87万 - 项目类别:
相似海外基金
Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
- 批准号:
BB/Y003454/1 - 财政年份:2024
- 资助金额:
$ 28.87万 - 项目类别:
Research Grant
Comparative single-cell analysis of disease-derived stem cells to identify the cell fate defect on the cell differentiation trajectory
对疾病来源的干细胞进行比较单细胞分析,以确定细胞分化轨迹上的细胞命运缺陷
- 批准号:
23H02466 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
- 批准号:
23K06661 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
- 批准号:
10578000 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Mechanisms mediating human enteroendocrine cell differentiation and function
介导人肠内分泌细胞分化和功能的机制
- 批准号:
10739834 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
New strategies in cell replacement therapies for diabetes: role of USP7 in iPSC and adult organoids beta cell differentiation
糖尿病细胞替代疗法的新策略:USP7 在 iPSC 和成体类器官 β 细胞分化中的作用
- 批准号:
MR/X01813X/1 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Research Grant
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
- 批准号:
23K16122 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
- 批准号:
10731854 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Exhaustive Identification of Essential Genes for Human Taste Cell Differentiation ~Development of a Method for Inducing Differentiation of Taste Buds from ES/iPS Cells~
彻底鉴定人类味觉细胞分化必需基因~开发诱导ES/iPS细胞味蕾分化的方法~
- 批准号:
23K09214 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)